We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Jagannath - Elotuzumab in Combination with Lenalidomide and Low-Dose Dexamethasone in High-Risk and/or Stage 2-3 Relapsed and/or Refractory Multiple Myeloma: A Retrospective Subset Analysis of the Phase 2 Study
Sundar Jagannath, MD
Mount Sinai Medical Center
New York, New York, USA
12.06.11

Be the first to comment

 related articles